IDEXX LABORATORIES INC /DE IDXX revenue by segment, product and geography
In its fiscal year ending 2025-12-31, IDEXX LABORATORIES INC /DE reported revenue across 2 products and services; the largest, Product, was $2.54B, 59.0% of the filed sum (+12.9% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Product$2.54B59.0%+12.9% yoy
- Service$1.76B41.0%+7.0% yoy
Members sum to the consolidated $4.3B for this period.
- Americas$3.01Bshare n/a+8.7% yoy
- United States$2.75Bshare n/a+8.7% yoy
- EMEA$937Mshare n/a+16.2% yoy
- Asia Pacific$356Mshare n/a+10.9% yoy
- Europethe Middle Eastand Africa Other$230Mshare n/a+17.2% yoy
- Germany$207Mshare n/a+19.0% yoy
- Canada$167Mshare n/a+9.4% yoy
- United Kingdom$154Mshare n/a+14.7% yoy
- +10 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Product$666M58.4%+16.2% yoy
- Service$475M41.6%+11.6% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.